We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Apr 20
The late-stage trial will evaluate the use of Jakavi for the treatment of cytokine storm associated with the…
24 Mar 20
Actemra is a humanised interleukin-6 (IL-6) receptor antagonist intended for the treatment of moderately to severely active rheumatoid…
20 Mar 20
The study will assess the safety and efficacy of Actemra in combination with standard of care compared to…
18 Mar 20
The two trials (COUGH 1 and 2) involved nearly 2,000 people with chronic cough due to unknown causes…
Moderna has already given a dose of its potential Covid-19 vaccine to a patient
17 Mar 20
Baricitinib is already approved to treat moderately to severely active rheumatoid arthritis in adults
16 Mar 20
The study was evaluating Bavencio in addition to CRT in comparison to standard-of-care CRT in patients having untreated…
09 Mar 20
The IND approval will enable the company to ship eftilagimod across US state borders to clinical investigators participating…
27 Feb 20
Gilead has started the clinical studies, following the US Food and Drug Administration (FDA) acceptance of its investigational…
In clinical trials, the new IV treatment was shown to reduce symptoms of migraines — including headaches, nausea…